Document is current
Any future updates will be listed below
-
Authors
Hoda, Yuki https://orcid.org/0009-0009-8333-5378
Shimizu, Keiji
Nishida, Hiroyuki
Ikari, Yasuhiko https://orcid.org/0000-0001-8728-5130
Akamatsu, Go https://orcid.org/0000-0001-9686-8901
Matsumoto, Keiichi
Senda, Michio https://orcid.org/0000-0002-7520-0942
Yamane, Tomohiko https://orcid.org/0000-0003-0955-4272
- License Information
-
More Information
Article History
Received: 21 May 2025
Accepted: 25 November 2025
First Online: 4 December 2025
Declarations
:
: The study protocol was registered in the UMIN Clinical Trials Registry (UMIN000051687). This study was approved by the Kobe City Medical Center General Hospital Research Ethics Committee (#23073).
: Written informed consent was obtained from all participants included in the study.
: The precursor of 18 F-FAPI-74 was purchased from SOFIE. Yasuhiko Ikari is an employee of CMIC Co., Ltd. Hiroyuki Nishida is an employee of Micron, Inc. The other authors declare that they have no conflict of interest relevant to this report.
